Gabriel de
Arriba de la Fuente
Catedrático/a de Universidad
Hospital Vall d'Hebron
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Vall d'Hebron (9)
2022
-
Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients
Transplantation, Vol. 106, Núm. 7, pp. 1430-1439
-
Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum
Clinical journal of the American Society of Nephrology : CJASN
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
-
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA
Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151
-
Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy
Scientific Reports, Vol. 12, Núm. 1
2021
-
Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis
Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320
-
Predictors of outcome in a Spanish cohort of patients with Fabry disease on enzyme replacement therapy
Nefrologia, Vol. 41, Núm. 6, pp. 652-660
2004
-
Perceived health-related quality of life and comorbidity in diabetic patients starting dialysis (CALVIDIA study)
Journal of Nephrology, Vol. 17, Núm. 4, pp. 544-551
-
Perceived mental health at the start of dialysis as a predictor of morbidity and mortality in patients with end-stage renal disease (CALVIDIA study)
Nephrology Dialysis Transplantation, Vol. 19, Núm. 9, pp. 2347-2353